13F HOLDINGS REPORT
Medicxi Ventures Management (Jersey) Ltd
Quarter ended Q3 2024 · Filed October 15, 2024 · Accession 0000950123-24-009687
Total Value
$528.9M
Positions
4
Other Managers
1
Confidential Omitted
No
Holdings (4)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CENTESSA PHARMACEUTICALS PLC | CNTA | 19,963,157 | $319.2M | 60.35% |
| 2 | PHATHOM PHARMACEUTICALS INC | PHAT | 7,464,572 | $135.0M | 25.52% |
| 3 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 2,869,565 | $47.6M | 9.01% |
| 4 | AURA BIOSCIENCES INC | AURA | 3,039,892 | $27.1M | 5.12% |